XOMA - XOMA Corp
IEX Last Trade
28.86
0 0%
Share volume: 0
Last Updated: Fri 20 Dec 2024 09:01:15 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.46%
PREVIOUS CLOSE
CHG
CHG%
$28.86
-3.36
0.13%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-03-09 | 2023-05-09 | 2023-08-08 | 2023-11-07 | 2024-03-08 | 2024-05-09 | |
| Total revenue | 983.000 K | 451.000 K | 1.486 M | 437.000 K | 1.658 M | 830.000 K | 1.833 M | 1.490 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 983.000 K | 451.000 K | 1.486 M | 437.000 K | 1.658 M | 830.000 K | 1.833 M | 1.490 M | |
| -54.12% | 229.49% | -70.59% | 279.41% | -49.94% | 120.84% | -18.71% | |||
| Operating expenses | 5.750 M | 4.823 M | 7.599 M | 6.250 M | 5.816 M | 6.393 M | 7.290 M | 8.494 M | |
| Selling general and admin | 5.710 M | 4.794 M | 7.571 M | 6.196 M | 5.777 M | 6.368 M | 7.265 M | 8.461 M | |
| Research and development | 40.000 K | 29.000 K | 28.000 K | 54.000 K | 39.000 K | 25.000 K | 25.000 K | 33.000 K | |
| Total expenses | 5.750 M | 4.823 M | 7.696 M | 6.475 M | 6.040 M | 6.617 M | 7.514 M | 8.494 M | |
| -16.12% | 59.57% | -15.87% | -6.72% | 9.55% | 13.56% | 13.04% | |||
| Operating income | -4.767 M | -4.372 M | -6.210 M | -6.038 M | -4.382 M | -5.787 M | -5.681 M | -7.004 M | |
| Ebit | -4.767 M | -4.372 M | -6.210 M | -6.038 M | -4.382 M | -5.787 M | -5.681 M | -7.004 M | |
| Pretax income | -4.670 M | -4.178 M | -5.991 M | -9.813 M | -5.400 M | -5.509 M | -20.109 M | -8.595 M | |
| -10.54% | 43.39% | 63.80% | -44.97% | 2.02% | 265.02% | -57.26% | |||
| Income tax | 0.000 | 0.000 | -15.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -6.038 M | -5.546 M | -7.344 M | -11.181 M | -6.768 M | -6.877 M | -21.477 M | -9.963 M | |
| 8.15% | -32.42% | -52.25% | 39.47% | -1.61% | -212.30% | 53.61% | |||
| Net income | -6.038 M | -5.546 M | -7.344 M | -11.181 M | -6.768 M | -6.877 M | -21.477 M | -9.963 M | |
| 8.15% | -32.42% | -52.25% | 39.47% | -1.61% | -212.30% | 53.61% |